BioCT welcomes Megan Rosengarten to Board
BioCT is pleased to welcome Megan Rosengarten to the BioCT Board of Directors. Megan is a proven leader known for commercializing new insights and opportunities, resulting in...
Home >
Access the latest news, business developments, company updates, industry trends, events and more.
BioCT is pleased to welcome Megan Rosengarten to the BioCT Board of Directors. Megan is a proven leader known for commercializing new insights and opportunities, resulting in...
Biohaven Pharmaceutical Holding Company has received orphan drug designation from the FDA for its product candidate verdiperstat (previously BHV-3241), a novel myeloperoxidase inhibitor, for the treatment of...
Yale researchers have developed a new way to efficiently engineer immune cells, an advance which enhances the ability to fend off cancer and other diseases....